Digital Mammographic Imaging Screening Trial

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Digital Mammographic Imaging Screening Trial" – news · newspapers · books · scholar · JSTOR (March 2024) (Learn how and when to remove this message)

|

The Digital Mammographic Imaging Screening Trial (DMIST) is a multi-institutional research study, beginning in 2001, on the efficacy for screening of full-field digital mammography (FFDM) compared to conventional film-screen mammography that was sponsored by the U.S. National Cancer Institute and performed by the American College of Radiology Imaging Network (ACRIN).[1]

The findings[2][3] that FFDM was not inferior to the existing technology, and potentially superior in younger women with dense breasts, has led to a rapid proliferation of digital systems in the US.[citation needed] On the other hand, women with dense breasts receive two to three times the amount of radiation during their imaging as dense breasts absorb more X-ray because of the density (difficulty of the X-ray to penetrate dense tissue).[citation needed]

## References

[edit]

1. ^ Galen, Barbara; Staab, Edward; Sullivan, Daniel C.; Pisano, Etta D. "American College of Radiology Imaging Network: The Digital Mammographic Imaging Screening Trial—An Update" (PDF). National Cancer Institute. Retrieved 13 December 2023.
2. ^ Pisano, Etta (27 October 2005). "Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening". New England Journal of Medicine. 353 (17). NEJM: 1773–1783\. doi:10.1056/NEJMoa052911. PMID 16169887. Retrieved 11 February 2010.
3. ^ Dershaw, D. David (2005). "Film or Digital Mammographic Screening?". New England Journal of Medicine. 353 (17): 1846–1847\. doi:10.1056/NEJMe058253.